OncoSec Medical Inc. (ONCS.OB)

OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology. The company's immunotherapy program uses the OncoSec Medical System to deliver engineered DNA plasmid constructs that encode a specific cytokine. It has three Phase II clinical trials underway with its OMS ElectroImmunotherapy product. The company was formerly known as NetVentory Solutions, Inc. and changed its name to OncoSec Medical Incorporated in March 2011 on completion of a merger with its subsidiary. OncoSec Medical Incorporated is based in San Diego, California.